Serum retinol-binding protein concentration and its association with components of the uremic metabolic syndrome in nondiabetic patients with chronic kidney disease stage 5

American Journal of Nephrology

Volumn 29, Issue 5, 2009, Pages 447-453

  Axelsson, Jonas ^a,c   O'Byrne, Sheila M ^b   Blaner, William S ^b   Carrero, Juan Jesús ^a   Bruchfeld, Annette ^a   Heimbürger, Olof ^a   Bárány, Peter ^a   Lindholm, Bengt ^a   Stenvinkel, Peter ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Columbia University ^*  (United States)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

End stage renal disease; Insulin resistance; Obesity; RBP 4; Vitamin A

Indexed keywords

ALBUMIN; APOLIPOPROTEIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; C REACTIVE PROTEIN; GLUCOSE; HEMOGLOBIN A1C; INSULIN; INTERLEUKIN 6; PREALBUMIN; RETINOL; RETINOL BINDING PROTEIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY COMPOSITION; BODY FAT; BODY MASS; CHRONIC KIDNEY DISEASE; DIET RESTRICTION; DISEASE MARKER; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INFLAMMATION; INSULIN RESISTANCE; LEAN BODY WEIGHT; LIPOPROTEIN METABOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; UREMIA;

ADULT; APOLIPOPROTEIN A-I; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INSULIN RESISTANCE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY; REGRESSION ANALYSIS; RETINOL-BINDING PROTEINS; UREMIA; VITAMIN A;

EID: 56349109153     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000176534     Document Type: Article

References (28)

1. Yang Q, Graham TE, Mody N, et al: Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 2005;436:356-362.
2. Liz MA, Faro CJ, Saraiva MJ, Sousa MM: Transthyretin, a new cryptic protease. J Biol Chem 2004;279:21431-21438.
3. Axelsson J, Rashid Qureshi A, Suliman ME, et al: Truncal fat mass as a contributor to inflammation in end-stage renal disease. Am J Clin Nutr 2004;80:1222-1229.
4. Stenvinkel P, Carrero JJ, Axelsson J, et al: Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle? Clin J Am Soc Nephrol 2008;3:505-521.
5. Muntner P, Hamm LL, Kusek JW, et al: The prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease. Ann Intern Med 2004; 140:9-17.
6. Axelsson J, Stenvinkel P: Role of fat mass and adipokines in chronic kidney disease. Curr Opin Nephrol Hypertens 2008; 17:25-31.
7. DeFronzo RA, Alvestrand A, Smith D, et al: Insulin resistance in uremia. J Clin Invest 1981;67:563-568.
8. Becker B, Kronenberg F, Kielstein JT, et al: Renal insulin resistance syndrome, adipo-nectin and cardiovascular events in patients with kidney disease: the mild and moderate kidney disease study. J Am Soc Nephrol 2005;16:1091-1098.
9. Rigalleau V, Gin H: Carbohydrate metabolism in uraemia. Curr Opin Clin Nutr Metab Care 2005;8:463-469.
10. Cabre A, Lazaro I, Girona J, et al: Retinol-binding protein 4 as a plasma biomarker of renal dysfunction and cardiovascular disease in type 2 diabetes. J Intern Med 2007; 262:496-503.
11. Raila J, Henze A, Spranger J, Mohlig M, et al: Microalbuminuria is a major determinant of elevated plasma retinol-binding protein 4 in type 2 diabetic patients. Kidney Int 2007;72: 505-511.
12. Ziegelmeier M, Bachmann A, Seeger J, et al: Serum levels of adipokine retinol-binding protein-4 in relation to renal function. Diabetes Care 2007;30:2588-2592.
13. Stenvinkel P, Heimbiirger O, Paultre F, et al: Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 1999; 55:1899-1911.
14. Organization WH: Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. 1. Diagnosis and Classification of Diabetes Mellitus. Geneva, World Health Organization, 1999.
15. Blaner WS: Radioimmunoassays for retinol-binding protein, cellular retinol-binding protein, and cellular retinoic acid-binding protein. Methods Enzymol 1990; 189:270-281.
16. Friedman GD, Blaner WS, Goodman DS, et al: Serum retinol and retinol-binding protein levels do not predict subsequent lung cancer. Am J Epidemiol 1986;123:781-789.
17. Heimburger O, Qureshi AR, Blaner WS, et al: Hand-grip muscle strength, lean body mass, and plasma proteins as markers of nutritional status in patients with chronic renal failure close to start of dialysis therapy. Am J Kidney Dis 2000;36:1213-1225.
18. Heimburger O, Qureshi AR, Blaner WS, et al: Hand-grip muscle strength, lean body mass, and plasma proteins as markers of nutritional status in patients with chronic renal failure close to start of dialysis therapy. Am J Kidney Dis 2000;36:1213-1225.
19. Shapiro SS, Wilk MB: An analysis of variance test for normality (complete samples). Biometrika 1965;52:591-611.
20. Graham TE, Yang Q, Bluher M, et al: Reti-nol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med 2006;354:2552-2563.
21. Promintzer M, Krebs M, Todoric J, et al: Insulin resistance is unrelated to circulating retinol binding protein and protein C inhibitor. J Clin Endocrinol Metab 2007;92:4306-4312.
22. Haider DG, Schindler K, Prager G, et al: Serum retinol-binding protein 4 is reduced after weight loss in morbidly obese subjects. J Clin Endocrinol Metab 2007;92:1168-1171.
23. Kloting N, Graham TE, Berndt J, et al: Serum retinol-binding protein is more highly expressed in visceral than in subcutaneous adipose tissue and is a marker of intra-abdom-inal fat mass. Cell Metab 2007;6:79-87.
24. Stewart WK, Fleming LW: Plasma retinol and retinol binding protein concentrations in patients on maintenance haemodialysis with and without vitamin A supplements. Nephron 1982;30:15-21.
25. Ng TW, Watts GF, Barrett PH, et al: Effect of weight loss on LDL and HDL kinetics in the metabolic syndrome: associations with changes in plasma retinol-binding protein-4 and adiponectin levels. Diabetes Care 2007; 30:2945-2950.
26. Wongsiriroj N, Piantedosi R, Palczewski K, Goldberg I, Johnston TP, Li E, Blaner WS: The molecular basis of retinoid absorption: a genetic dissection. J Biol Chem 2008;283: 13510-13519.
27. Reid BN, Abies GP, Otlivanchik OA, et al: Hepatic overexpression of hormone-sensitive lipase and adipose triglyceride lipase promotes fatty acid oxidation, stimulates direct release of free fatty acids and ameliorates steatosis. J Biol Chem 2008;283:13087-13099.
28. Kalantar-Zadeh K: Inflammatory marker mania in chronic kidney disease: pentraxins at the crossroad of universal soldiers of inflammation. Clin J Am Soc Nephrol 2007;2: 872-875.